Prudential Financial
IGMS

Prudential Financial’s IGM Biosciences IGMS Stock Holding History

Prudential Financial’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-65,870
Closed -$547K – 2703
2023
Q4 		$547K Buy
+65,870
New +$382K ﹤0.01% 2104
2023
Q3 		– Sell
-12,070
Closed -$111K – 2641
2023
Q2 		$111K Buy
+12,070
New +$135K ﹤0.01% 2475

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prudential Financial's IGMS Position: Q1 2024 in Review

Prudential Financial sold out of IGM Biosciences (IGMS) in Q1 2024, closing a stake of 65,870 shares — an estimated $547K sold.

Prudential Financial first reported a position in IGMS in Q2 2023 and held it in 2 quarters. The position peaked at $547K in Q4 2023. 87 funds tracked by Wall St. Rank hold IGMS as of Q1 2024.

  • Prudential Financial reported no remaining IGM Biosciences position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 65,870 IGM Biosciences shares in Q1 2024, an estimated $547K.
  • Prudential Financial first reported a position in IGM Biosciences in Q2 2023 and held it in 2 quarters.
  • Prudential Financial's IGM Biosciences position peaked at $547K in Q4 2023.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.